Home › Trial NCT06455046
Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer
- Trial IDNCT06455046
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorFujian Cancer Hospital
- Enrollment37
- Start date2023-10-11
- ConditionsCervical Cancer Recurrent
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.